

Author: Black M. Lanthorn T. Small D. Mealing G. Lam V. Morley P.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.317, Iss.2, 1996-12, pp. : 377-381
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


NR2B Selective NMDA Receptor Antagonists
Current Pharmaceutical Design, Vol. 8, Iss. 10, 2002-05 ,pp. :


By Yang Ming Soohoo Daniel Soelaiman Sandriyana Kalla Rao Zablocki Jeff Chu Nancy Leung Kwan Yao Lina Diamond Ivan Belardinelli Luiz Shryock John
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 2, 2007-04 ,pp. :




NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004
Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. :